| Name | Gavilimomab |
|---|
| Description | Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD)[1]. |
|---|---|
| Related Catalog | |
| Target |
CD147[1] |
| References |
| No Any Chemical & Physical Properties |